Trials / Completed
CompletedNCT03554876
Randomized and Controlled Clinical Trial to Evaluate Bacterial Adhesion on Multi-Im® Transepithelial Components
Randomized and Controlled Clinical Trial to Evaluate Bacterial Adhesion on Multi-Im® Transepithelial Components Placed on Implants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Fundación Eduardo Anitua · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy of Mutli-Im® transepithelial components in the inhibition of bacterial adhesion. The control group will be the Multi-Im® transepithelial component with the conventional surface (Multi-IM® Machined) and the experimental group will be the Multi-Im transepithelial components with the Ti-Golden® surface (Multi-Im Golden) or with the nanogolden surface (Multi-Im® nanogolden). Periodontal indices and biofilformation will be assessed during 2 months after implant loading. Metagenomic analysis and PCR technique will be implemented to assess the biofilm formation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Multi-Im Machined transepithelial component. | Once the implant is placed, the implant loading protocol will be decided following the clinical criteria. When implant loading is to be done, then the Multi-IM machined transepithelial component is connected to the implant. |
| DEVICE | Multi-Im Nanogolden transepithelial component | Once the implant is placed, the implant loading protocol will be decided following the clinical criteria. When implant loading is to be done, then the Multi-IM Nanogolden transepithelial component is connected to the implant. |
| DEVICE | Multi-Im Ti-Golden transepithelial component | Once the implant is placed, the implant loading protocol will be decided following the clinical criteria. When implant loading is to be done, then the Multi-IM Ti-Golden transepithelial component is connected to the implant. |
Timeline
- Start date
- 2018-07-16
- Primary completion
- 2020-12-22
- Completion
- 2020-12-22
- First posted
- 2018-06-13
- Last updated
- 2025-02-25
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03554876. Inclusion in this directory is not an endorsement.